|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2001-2-13
|
|
pubmed:abstractText |
To determine the pharmacokinetics of ceftazidime following subcutaneous administration and continuous IV infusion to healthy dogs and to determine the minimum inhibitory concentration (MIC) of ceftazidime for clinical isolates of Pseudomonas aeruginosa.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0002-9645
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
61
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1204-8
|
|
pubmed:dateRevised |
2003-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11039548-Animals,
pubmed-meshheading:11039548-Ceftazidime,
pubmed-meshheading:11039548-Cephalosporins,
pubmed-meshheading:11039548-Chromatography, High Pressure Liquid,
pubmed-meshheading:11039548-Disease Susceptibility,
pubmed-meshheading:11039548-Dog Diseases,
pubmed-meshheading:11039548-Dogs,
pubmed-meshheading:11039548-Infusions, Intravenous,
pubmed-meshheading:11039548-Injections, Subcutaneous,
pubmed-meshheading:11039548-Microbial Sensitivity Tests,
pubmed-meshheading:11039548-Pseudomonas Infections,
pubmed-meshheading:11039548-Pseudomonas aeruginosa
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Pharmacokinetics of ceftazidime in dogs following subcutaneous administration and continuous infusion and the association with in vitro susceptibility of Pseudomonas aeruginosa.
|
|
pubmed:affiliation |
Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison 53706, USA.
|
|
pubmed:publicationType |
Journal Article
|
